NCT03560973 2025-03-13
RAMES
Gruppo Oncologico Italiano di Ricerca Clinica
Phase 2 Completed
Clinical Trials
6 trialsNCT01515306 2022-03-08
A Study of Ramucirumab (IMC-1121B) and Paclitaxel in Participants With Solid Tumors
Eli Lilly and Company
Phase 2 Completed
NCT01634555 2019-02-26
A Study to Assess the Pharmacokinetics of Ramucirumab (IMC-1121B) in Combination With FOLFIRI
Eli Lilly and Company
Phase 2 Completed
NCT01682135 2016-08-26
A Study in Participants With Advanced Solid Tumors
Eli Lilly and Company
Phase 1 Completed
NCT01567163 2014-10-16
A Study of Ramucirumab and Docetaxel in Participants With Solid Tumors
Eli Lilly and Company
Phase 2 Completed
NCT01005355 2014-06-18
Study of IMC-1121B in Patients With Advanced Solid Tumors
Eli Lilly and Company
Phase 1 Completed